Immunological pathogenesis of main age-related diseases and frailty: Role of immunosenescence

European Geriatric Medicine

Volumn 1, Issue 2, 2010, Pages 112-121

  Lang, P O ^b   Mitchell, W A ^a   Lapenna, A ^a   Pitts, D ^a   Aspinall, R ^a  

^a CRANFIELD UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Age related diseases; Ageing; Frailty; Immunosenescence; Pathogenesis

Indexed keywords

CD4 ANTIGEN; CD40 LIGAND; CD45RA ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; AGING; ALZHEIMER DISEASE; ARTICLE; B LYMPHOCYTE; CANCER GROWTH; CARCINOGENESIS; DENDRITIC CELL; DISEASE PREDISPOSITION; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOREGULATION; INFECTION; INNATE IMMUNITY; INSULIN RESISTANCE; MACROPHAGE; NATURAL KILLER CELL; NEUTROPHIL; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATHOGENESIS;

EID: 77953671876     PISSN: 18787649     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurger.2010.01.010     Document Type: Article

References (82)

1. Weiskopf D., Weinberger D., and Grubeck-Loebenstein B. The aging of the immune system. Transpl Int 22 (2009) 1041-1050
2. Malaguarnera L., Cristaldi E., and Malaguarnera M. The role of immunity in elderly cancer. Crit Rev Oncol Hematol (2009) [Epub ahead of print]
3. McElhaney J.E., and Effros R.B. Immunosenescence: what does it mean to health outcomes in older adults?. Curr Opin Immunol 21 (2009) 418-424
4. Giunta B., Fernandez F., Nikolic W.V., Obregon D., Rrapo E., Town T., et al. Inflammaging as a prodrome to Alzheimer's disease. J Neuroinflammation 5 (2008) 51
5. Weinberger B., Herndler-Brandstetter D., Schwanninger A., Weiskopf D., and Grubeck-Loebenstein B. Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 46 (2008) 1078-1084
6. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128 (2007) 92-105
7. De Martinis M., Di Benedetto M.C., Mengoli L.P., and Ginaldi L. Senil osteoporosis: is it an immune-mediated disease?. Inflamm Res 55 (2006) 399-404
8. Fulop T., Pawelec G., Castle P., and Loeb M. Immunosenescence and vaccination in nursing home residents. Clin Infect Dis 48 (2009) 443-448
9. Wikby A., Nilsson B.O., Forsey R., Thompson J., Strindhall J., Löfgren S., et al. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev 127 (2006) 695-704
10. Lang A., Brien J.D., Messaoudi I., and Nikolich-Zugich J. Age-related dysregulation of CD8+ T cell memory specific for a persistent virus is independent of viral replication. J Immunol 180 (2008) 4848
11. Pawelec G., Derhovanessian E., Larbi A., Strindhall J., and Wikby A. Cytomegalovirus and human immunosenescence. Rev Med Virol 19 (2009) 47-56
12. Gibson K.L., Wu Y.C., Barnett Y., Duggan O., Vaughan R., Kondeatis E., et al. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 8 (2009) 18-25
13. Castle S.C., Uyemura K., Fulop T., and Makinodan T. Host resistance and immune response in advanced age. Clin Geriatr Med 23 (2007) 463-479
14. Gavazzi G., and Krause K.H. Ageing and infection. Lancet Infect Dis 2 (2002) 659-666
15. Oxman M.N., Levin M.J., and Shingles Prevention Study Group. Vaccination against herpes zoster and post-herpetic neuralgia. J Infect Dis 197 Suppl 2 (2008) S228-S236
16. Martin G.S., Mannino D.M., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Eng J Med 348 (2003) 1546-1554
17. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., and Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 (2001) 1303-1310
18. Franceschi C., Bonafe M., and Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunobiological space. Vaccine 18 (2000) 1717-1720
19. George A.J., and Ritter M.A. Thymic involution with ageing: obsolescence or good housekeeping?. Immunol Today 17 (1996) 296-372
20. Pfister G., Weiskopf D., Lazuardi L., et al. Naive T-cells in the elderly: are they still there?. Ann N Y Acad Sci 1067 (2006) 152-157
21. Vallejo A.N. CD28 extinction in human T-cells: altered functions and the program of T-cell senescence. Immunol Rev 205 (2005) 158-169
22. Haynes L.E.S. The effect of age on the cognate function of CD4+ T cells. Immunol Rev 205 (2005) 220-228
23. Fulop T., Larbi A., Wikby A., Mocchegiani E., Hirokawa K., and Pawelec G. Dysregulation of T-cell function in the elderly: scientific basis and clinical implications. Drugs Aging 22 (2005) 589-603
24. Fulop T., Larbi A., Douziech N., Fortin C., Guérard K.P., Lesur O., et al. Signal transduction and functional changes in neutrophilis with aging. Aging Cell 3 (2004) 217-226
25. Grubeck-Loebenstein B., Della Bella S., Iorio A.M., Michel J.P., Pawelec G., and Solana R. Immunosenescence and vaccine failure in elderly. Aging Clin Exp Res 21 (2009) 201-209
26. Legrand J., Vergu E., and Flahault A. Real-time monitoring of the influenza vaccine field effectiveness. Vaccine 24 (2006) 6605-6611
27. Smith N.M., Bresee J.S., Shay D.K., Uyeki T.M., Cox N.J., and Strikas R.A. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55 RR-10 (2006) 1-42
28. Skowronski D.M., Tweed S.A., and De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?. J Infect Dis 197 (2008) 490-502
29. McElhaney J.E., and Hager WD X.D. T cells responses are better correlates of vaccine protection in the elderly. J Immunol 176 (2006) 6333-6339
30. RB E. Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 2007;25:599-604.
31. Herndler-Brandstetter D.V.E., Laschober G.T., et al. Non-regulatory CD8(+)CD45RO(+)CD25(+) T lymphocytes may compensate for the loss of antigen-inexperienced CD8(+)CD45RA(+) T cells in old age. Biol Chem 389 (2008) 561-568
32. Blasko I., Stampfer-Kountchev M., Robatscher P., Veerhuis R., Eikelenboom P., and Grubeck-Loebenstein B. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell 3 (2004) 169-176
33. Smith M., Kutty R., Richey P., Yan S., Stern D., Chader G., et al. Heme oxygenase-I is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 145 (1994) 42-47
34. Richartz-Salzburger E., and Koehler N. Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?. In: Fulop T., et al. (Eds). Handbook on immunosenescence (2009), Springer Science + Business Media MV 1275-1289 2009
35. McGeer E.G., and McGeer P.L. Inflammatory process in Alzheimer's disease. Prog Neuropsychopharmacol 27 (2003) 741-749
36. Akiyama A., Barger S., Barnum S., Bradt B., Brauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000) 383-421
37. Amara F.M., Junaid A., Clough R.R., and Liang B. TGF-beta (1), regulation of Alzheimer amyloid precursor protein nRNA expression in normal human astrocyte cell line: mRNA stabilization. Brain Res Mol Brain Res 71 (1999) 42-49
38. Rogers J.T., Leiter L.M., McPhee J., Cahill C.M., Zhan S.S., Potter H., et al. Translation to Alzheimer amyloid precursor protein mRNA is up regulated by interleukin-1 through 5'-untranslated region sequences. J Biol Chem 274 (1999) 6421-6431
39. Sastre M., Dewatcher I., Landreth G.E., Willson T.M., Klockgether T., Van Leuven F., et al. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonist modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase. J Neuroscience 96 (2003) 195-203
40. Blasko I., Marx F., Steiner E., Hartmann T., and Grubeck-Loebenstein B. TNF alpha plus IFN gamma induce the production of Alzheimer's disease beta amyloid peptides and decrease the secretion of APPs. FASEB J 13 (1999) 63-68
41. Lue L.F., Rydel R., Brigham E.E., Yang L.B., Hampel H., Murphy Jr. G.M., et al. Inflammatory repertoire of Alzheimer's disease and non demented elderly microglia in vitro. Glia 35 (2001) 72-79
42. Benzing W.C., Wujek J.R., Ward E.K., Shaffer D., Ashe K.H., Younkin S.G., et al. Evidence for glial-mediated inflammation in aged APP (SW) transgenic mice. Neurobiol Aging 20 (1999) 581-589
43. Smits H.A., Rijmus A., von Loon J.H., Wat J.W., Verhoef J., Boven L.A., et al. Amyloid beta induced chemokine production in primary human macrophages and astrocytes. J Neuroimmunol 127 (2002) 160-168
44. Malaguarnera M., Laurino A., Di Mauro S., Motta M., Di Fazio I., and Maugeri D. The comorbidities of elderly oncologic patients. Arch Gerontol Geriatr 30 (2000) 237-244
45. Zhang H.G., and Grizzle W.E. Aging, immunity, and tumor susceptibility. Immunol Allergy Clin North Am 23 (2003) 83-102
46. Kim R., Emi M., and Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology 121 (2007) 1-14
47. Dunn G.P., Old L.J., and Schreiber R.D. The three Es of cancer immunoediting. Annu Rev Immunol 22 (2004) 329-360
48. Lin W.W., and Karin M. A cytokine-mediated link between innate immunity, inflammation and cancer. J Clin Invest 117 (2007) 1175-1183
49. Balkwill F., Charles K.A., and Montovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7 (2005) 211-217
50. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., and Sethi G. Inflammation and cancer: how hot is the link?. Biochem Pharmacol 72 (2006) 1605-1621
51. Rose-John S., Sheller J., Ellson G., and Jones S.A. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 80 (2006) 226-236
52. Dinarello C.A. The paradox of pro-inflammatory cytokines in cancer. Cancer Metastasis Rev 25 (2006) 307-313
53. Arron J.R., and Choi Y. Bone versus immune system. Nature 408 (2000) 535-536
54. Ginaldi L., Di Benedetto M.C., and De Martinis M. Osteoporosis, inflammation and aging. Immun Aging 2 (2005) 14-18
55. Saidenberg-Kermanac'h N., Cohen-Solal M., Bessis N., De Vernejoul M.C., and Boissier. Role for osteoprotegerin in rheumtoid inflammation. Joint Bone Spine 71 (2004) 9-31
56. Takayanagi H., Ogasawara K., Hida S., Chiba T., Murata S., Sato K., et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANK and IFN-gamma. Nature 408 (2000) 600-605
57. Pacifici R., Rifas L., McCraken, and Avioli L.V. The role of interleukin-1 in postmenopausal bone loss. Exp Gerontol 25 (1993) 309-316
58. Kastelan D., Kastelan M., and Massari L.P. Possible association of psoriasis and reduced bone mineral density due to increased TNF-alpha and IL-6 concentrations. Med Hypotheses 67 (2006) 1403-1405
59. McMahon M.S., and Ueki Y. Does anti-TNF-alpha have a role in the treatment of osteoporosis. Bull NYU Hosp Jt Dis 68 (2008) 280-281
60. Theill L.E., Boyle W.J., and Penninger J.M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 20 (2002) 795-823
61. Ahmadpoor P., Reisi S., Makhdoomi K., Ghafari A., Sepehrvand N., and Rahimi E. Osteoporosis and related risk factors in renal transplant recipients. Transplant Proc 41 (2009) 2820-2822
62. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300 (2003) 1140-1142
63. Mazzati D.J., Karnik K., Oita R.C., and Powell J.R. Insulin resistance, chronic inflammation and the link with immunosenescence. In: Fulop T., Franceschi C., Hirokawa K., and Pawelec G. (Eds). Handbook of immunosenescence: basic understanding and clinical applications (2009), Springer Science + Business Media BV 1248-1272
64. Michel JP, et al. A. Sarcopenia: a new topic in geriatrics. Rev Med Suisse 2009; 224(2200):2202-2204.
65. Ferrucci L., Cavazzini C., Corsi A., Bartali B., Russo C.R., Lauretani F., et al. Biomarkers of frailty in older adults. J Endocrinol Invest 25 (2003) 10-15
66. Rizzo M.R., Abbatecola A.M., Barbieri M., Vietri M.T., Cioffi M., Grella R., et al. Evidence for anti-inflammatory effects of combined administration of vitamin E and C in older persons with impaired fasting glucose: impact on insulin resistance. J Am Coll Nutr 27 (2008) 505-511
67. Lebrun P., and Van Obberghen E. SOCS proteins causing trouble in insulin action. Acta Physiol (Oxf) 192 (2008) 29-36
68. Lang P.O., Michel J.P., and Zekry D. Frailty syndrome: a transitional state in a dynamic process. Gerontology 55 (2009) 539-549
69. Mann G.E., Yudilevich D.L., and Sobrevia L. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83 (2003) 183-252
70. Fried L.P., Xue Q.L., Cappola A.R., Ferrucci L., Chaves P., Varadhan R., et al. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci 64 (2009) 1049-1057
71. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., et al., Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56 (2001) M146-M156
72. Walston J., McBurnie M.A., Newman A., Tracy R.P., Kop W.J., Hirsch C.H., et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the cardiovascular health study. Arch Intern Med 162 (2002) 2333-2341
73. Semba R.D., Margolick J.B., Leng S., Walston J., Ricks M.O., and Fried L.P. T cell subsets and mortality in older community-dwelling women. Exp Gerontol 40 (2005) 81-87
74. Giunta S. Exploring complex relations between inflammation and aging (inflamm-aging): anti-inflamm-aging remodelling of inflamm-aging, from robustness to frailty. Inflamm Res 57 (2008) 558-563
75. Leng S.X., Cappola A.R., Andersen R.E., Blackman M.R., Koenig K., Blair M., et al. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 16 (2004) 153-157
76. Leng S.X., Hung W., Cappola A.R., Yu Q., Xue Q.L., and Fried L.P. White blood cells and insulin-like growth factor-1 levels and frailty in community-dwelling older women. J Gerontol A Biol Sci Med Sci 64 (2009) 499-502
77. Cappola A.R., Xue Q.L., and Fried L.P. Multiple hormonal deficiencies in anabolic hormones are found in frail older women: the Women's Health and Aging studies. J Gerontol A Biol Sci Med Sci 64 (2009) 132-137
78. Leng S., Chaves P., Koenig K., and Walston J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 50 (2002) 1268-1271
79. Abbatecola A.M., and Paolisso G. Is there a relationship between insulin resistance and frailty syndrome?. Curr Pharm Des 14 (2008) 405-410
80. Janssen I., Heymsfield S.B., and Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50 (2002) 889-896
81. Morley J.E. Diabetes, sarcopenia and frailty. Clin Geriatr Med 24 (2008) 455-469
82. Fulop T., Franceschi C., Hirokawa K., and Pawelec G. Perspectives: is immunosenescence clinically relevant?. In: Fulop T., Franceschi C., Hirokawa K., and Pawelec G. (Eds). Handbook of immunosenescence: basic understanding and clinical applications (2009), Springer Science + Business Media BV 1647-1648 1648